Marc Beer – article recap

Marc Beer is an experienced businessman who is the founder of the current Chief Executive Officer of Renovia Inc. Renovia Inc is a medical technology company that has its main headquarters in Boston. Marc Beer is not new in this industry as he has over twenty five years of experience in biotechnology, pharmaceutical, and diagnostic development, Marc beer is also very experienced in commercialization, and he is responsible for the success of some Medtech companies that he has worked in as a leader. In 2000, Marc Beer was the CEO of the biotechnology company ViaCell and this company was responsible for the development, preservation, and collection of blood cells to be used in the umbilical cord.


Under Marc Beer’s leadership, ViaCell grew and became a successful company employing close to 300 people. Marc Beer has also founded a number of companies one of which is Good Start Genetics Compensation Committee. Marc Beer has made major strides in his career, and the most recent one is the Renovia Inc institution that he established in order to help women that are experiencing pelvic floor disorders. The company does this through the delivery of therapeutic and diagnostic devices. The devices are top-notch quality and digital, and the institution continues to look for new devices that can be used by women suffering from this disorder. Renovia Inc announced their move in financing Series B with 42.3 million dollars. The main purpose of this funding is to help the company to conduct trials, launches and product development in the future. The funding was divided into two with 32.3 million dollars and $10 million that would be used in debt.


The funding of the series B was held by top healthcare institutions in the world such as Perceptive Advisors, Longwood fund, Ascension Ventures, OSF Ventures, Western Technology Investment, and Inova Strategic investments. Marc Beer deeply honored the partaking of other healthcare institutions in the funding and was grateful for the support that they offered. Marc Beer was happy to see that other firms shared the same interest that he had which were to help individuals that were living with pelvic floor disorders. Through this funding, Marc Beer will be able to do this by properly diagnosing the disease and finding new treatment options that are more effective.


All the institutions that participated in the funding will be able to combine their technologies to develop scientific data that their customers can use to gain knowledge on the treatment options that are available for the disorder. The primary goal for this funding is to significantly cut the costs that are required for pelvic floor disorders and make the public aware and knowledgeable of the disease. Learn more: